Latest filing published 22 Sept 2011 for Zogenix, INC., €1.8M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Scale Venture Partners II, LP: trading record in brief
Scale Venture Partners II, LP discloses dealings in 3 companies, chiefly Orexigen Therapeutics, Inc., Zogenix, Inc. and Horizon Therapeutics Public Ltd Co. We count 129 filings; the first trade dates from 1 May 2007 and the latest from 21 September 2011.
The open-market side counts 4 purchases for €9.4M alongside 118 sales for €851k. Purchases outweigh sales by €8.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2011: 2 purchases and no sales on the market.
Half of the purchases are above €1.9M and half below.
Most recently, on 22 September 2011, the filings show an open-market purchase worth €1.8M in Zogenix, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Scale Venture Partners II, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,250,000 shares@ US$2.00Common StockSEC:0001209191-11-048745:0Canonical exit: 20 Dec 2011 (T+90)
- 171,626 sharesCommon StockSEC:0001209191-11-042516:1
- 1,370,070 sharesCommon StockSEC:0001209191-11-042516:0
- 346,823 shares@ US$9.00Common StockSEC:0001209191-11-042516:2
- 315,946 shares@ US$9.00Common StockSEC:0001209191-11-042516:3Canonical exit: 31 Oct 2011 (T+90)
- 1,400,000 sharesCommon StockSEC:0001209191-10-057213:0
- 831,901 sharesCommon StockSEC:0001209191-10-057213:1
- 589,645 shares@ US$4.00Common StockSEC:0001209191-10-057213:2Canonical exit: 24 Feb 2011 (T+90)
- 1,250,000 shares@ US$4.00Common StockSEC:0001209191-10-057213:3Canonical exit: 27 Feb 2011 (T+90)
- 100 shares@ US$15.00Common StockSEC:0001209191-07-065805:0
- 600 shares@ US$15.00Common StockSEC:0001209191-07-065504:0
- 200 shares@ US$15.02Common StockSEC:0001209191-07-065504:1
- 1,000 shares@ US$15.01Common StockSEC:0001209191-07-065504:2
- 186 shares@ US$15.13Common StockSEC:0001209191-07-065504:3
- 14 shares@ US$15.10Common StockSEC:0001209191-07-065504:4
- 100 shares@ US$15.17Common StockSEC:0001209191-07-065504:5
- 100 shares@ US$15.04Common StockSEC:0001209191-07-065504:6
- 600 shares@ US$15.00Common StockSEC:0001209191-07-065504:7
- 800 shares@ US$15.58Common StockSEC:0001209191-07-065220:0
- 796 shares@ US$15.57Common StockSEC:0001209191-07-065220:1
- 600 shares@ US$15.56Common StockSEC:0001209191-07-065220:2
- 1,300 shares@ US$15.55Common StockSEC:0001209191-07-065220:3
- 6,300 shares@ US$15.5459Common StockSEC:0001209191-07-065220:4
- 700 shares@ US$15.54Common StockSEC:0001209191-07-065220:5
- 1,300 shares@ US$15.53Common StockSEC:0001209191-07-065220:6
25 of 128 declarations
